Actelion Email & Phone number of top level executives

Actelion
Healthcare, Pharmaceuticals, and Biotech
Actelion is a pharmaceutical company based in the United States. It was founded in 1997 and focuses on the discovery, development, and commercialization of innovative medicines to treat various rare, life-threatening diseases. The company's portfolio includes drugs for the treatment of pulmonary arterial hypertension, a rare and serious condition that affects the lungs and heart. Actelion is committed to improving the lives of patients by offering cutting-edge therapies that target unmet medical needs. In January 2017, the company was acquired by Johnson & Johnson for $30 billion.